The saga of the anti-parasitic drug continues.
What happened to ivermectin?
The saga of the anti-parasitic drug continues.
You may also like
Nouscom to present re‑treatment data in Lynch...
ViiV Healthcare to unveil new HIV treatment data at...
Almirall’s paediatric registration of Ebglyss for...
The Bloc appoints Jon Chapman as European Executive...
Early Genomic Indicators of Praziquantel Resistance in...
Flu Virus Interaction with Host Cell Machinery Mapped...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.